All In Biotech

Drug Trial Radar · NCT07519395

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

BALANCE - A Two-part, 26-week, Randomized, Double-Blind, Dose-rAnging, pLAcebo-coNtrolled, Phase 2b Study to Evaluate the effiCacy and safEty of Camlipixant in Adults With IBS-D and IBS-M

Last checked: Nov 20, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 420 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

420

Planned (sponsor's estimate)

Start

Apr 8, 2026

Primary completion

Mar 9, 2027

Study completion Jul 13, 2027

Sponsor

Lead sponsor
GlaxoSmithKlineGSK (GSK)
Sponsor type
Industry
First posted
Apr 9, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Sequential
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to evaluate the efficacy and safety of camlipixant in adults with IBS-D and IBS-M. The study has two parts. After the first part, some participants will be randomly chosen again to either get a higher dose or stop the drug.

Conditions

  • Irritable Bowel Syndrome

Interventions

  • PlaceboDrug

    Placebo to be administered

  • CamlipixantDrug

    Camlipixant to be administered

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Weekly Abdominal pain intensity (API) over Weeks 7 to 12Time frame: Baseline, Weeks 7 to 12 (time - average)

Locations

114 sites in 1 country. Site status is shown where the registry gives one.

  • GSK Investigational Site

    Anniston, Alabama · Recruiting

  • GSK Investigational Site

    Guntersville, Alabama · Recruiting

  • GSK Investigational Site

    Mobile, Alabama · Recruiting

  • GSK Investigational Site

    Saraland, Alabama · Recruiting

  • GSK Investigational Site

    Phoenix, Arizona · Recruiting

  • GSK Investigational Site

    Scottsdale, Arizona · Recruiting

  • GSK Investigational Site

    Tempe, Arizona · Recruiting

  • GSK Investigational Site

    Tucson, Arizona · Recruiting

  • GSK Investigational Site

    Anaheim, California · Recruiting

  • GSK Investigational Site

    Chula Vista, California · Recruiting

  • GSK Investigational Site

    Coronado, California · Recruiting

  • GSK Investigational Site

    Garden Grove, California · Recruiting

  • GSK Investigational Site

    Lancaster, California · Recruiting

  • GSK Investigational Site

    Lancaster, California · Recruiting

  • GSK Investigational Site

    Los Angeles, California · Recruiting

  • GSK Investigational Site

    Murrieta, California · Recruiting

  • GSK Investigational Site

    Pasadena, California · Recruiting

  • GSK Investigational Site

    San Diego, California · Recruiting

  • GSK Investigational Site

    San Diego, California · Recruiting

  • GSK Investigational Site

    Sherman Oaks, California · Recruiting

  • GSK Investigational Site

    West Hills, California · Recruiting

  • GSK Investigational Site

    Aurora, Colorado · Recruiting

  • GSK Investigational Site

    Colorado Springs, Colorado · Recruiting

  • GSK Investigational Site

    Lone Tree, Colorado · Recruiting

  • GSK Investigational Site

    Brandon, Florida · Recruiting

  • GSK Investigational Site

    Clearwater, Florida · Recruiting

  • GSK Investigational Site

    Coral Gables, Florida · Recruiting

  • GSK Investigational Site

    Doral, Florida · Recruiting

  • GSK Investigational Site

    Hialeah, Florida · Recruiting

  • GSK Investigational Site

    Homestead, Florida · Recruiting

  • GSK Investigational Site

    Jacksonville, Florida · Recruiting

  • GSK Investigational Site

    Kissimmee, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

Showing 40 of 114 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.